REPORT ID 4330

Global Targeted DNA/RNA Sequencing Market Size, Status and Forecast 2022

Publish Date
18-Dec-17
Pages
107
Format
Electronic (PDF)

This report studies the global Targeted DNA/RNA Sequencing market, analyzes and researches the Targeted DNA/RNA Sequencing development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    Illumina, Inc.
    F. Hoffmann-La Roche Ltd
    Agilent Technologies
    GATC Biotech Ag
    Oxford Nanopore Technologies
    Thermo Fisher Scientific, Inc.
    DNASTAR Inc.
    QIAGEN
    BGI
    Perkin Elmer, Inc.
    Pacific Biosciences of California, Inc.
    Bio-Rad Laboratories, Inc.
    Integrated DNA Technologies, Inc.
    RainDance Technologies, Inc.
    PierianDx
    Genomatix GmbH
    Macrogen, Inc.

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, the product can be split into
    DNA-based Targeted Sequencing
    RNA-based Targeted Sequencing

Market segment by Application, Targeted DNA/RNA Sequencing can be split into
    Human Biomedical Research
    Plant & Animal Sciences
    Drug Discovery
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.


 
			   
Table of Contents

Global Targeted DNA/RNA Sequencing Market Size, Status and Forecast 2022
1 Industry Overview of Targeted DNA/RNA Sequencing
    1.1  Targeted DNA/RNA Sequencing Market Overview
        1.1.1 Targeted DNA/RNA Sequencing Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Targeted DNA/RNA Sequencing Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Targeted DNA/RNA Sequencing Market by Type
        1.3.1 DNA-based Targeted Sequencing
        1.3.2 RNA-based Targeted Sequencing
    1.4 Targeted DNA/RNA Sequencing Market by End Users/Application
        1.4.1 Human Biomedical Research
        1.4.2 Plant & Animal Sciences
        1.4.3 Drug Discovery
        1.4.4 Others

2 Global Targeted DNA/RNA Sequencing Competition Analysis by Players
    2.1 Targeted DNA/RNA Sequencing Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Illumina, Inc.
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Targeted DNA/RNA Sequencing Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 F. Hoffmann-La Roche Ltd
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Targeted DNA/RNA Sequencing Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 Agilent Technologies
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Targeted DNA/RNA Sequencing Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 GATC Biotech Ag
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Targeted DNA/RNA Sequencing Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 Oxford Nanopore Technologies
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Targeted DNA/RNA Sequencing Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 Thermo Fisher Scientific, Inc.
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Targeted DNA/RNA Sequencing Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 DNASTAR Inc.
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Targeted DNA/RNA Sequencing Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 QIAGEN
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Targeted DNA/RNA Sequencing Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 BGI
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Targeted DNA/RNA Sequencing Revenue (Value) (2012-2017)
        3.9.5 Recent Developments
    3.10 Perkin Elmer, Inc.
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Targeted DNA/RNA Sequencing Revenue (Value) (2012-2017)
        3.10.5 Recent Developments
    3.11 Pacific Biosciences of California, Inc.
    3.12 Bio-Rad Laboratories, Inc.
    3.13 Integrated DNA Technologies, Inc.
    3.14 RainDance Technologies, Inc.
    3.15 PierianDx
    3.16 Genomatix GmbH
    3.17 Macrogen, Inc.

4 Global Targeted DNA/RNA Sequencing Market Size by Type and Application (2012-2017)
    4.1 Global Targeted DNA/RNA Sequencing Market Size by Type (2012-2017)
    4.2 Global Targeted DNA/RNA Sequencing Market Size by Application (2012-2017)
    4.3 Potential Application of Targeted DNA/RNA Sequencing in Future
    4.4 Top Consumer/End Users of Targeted DNA/RNA Sequencing

5 United States Targeted DNA/RNA Sequencing Development Status and Outlook
    5.1 United States Targeted DNA/RNA Sequencing Market Size (2012-2017)
    5.2 United States Targeted DNA/RNA Sequencing Market Size and Market Share by Players (2016 and 2017)

6 EU Targeted DNA/RNA Sequencing Development Status and Outlook
    6.1 EU Targeted DNA/RNA Sequencing Market Size (2012-2017)
    6.2 EU Targeted DNA/RNA Sequencing Market Size and Market Share by Players (2016 and 2017)

7 Japan Targeted DNA/RNA Sequencing Development Status and Outlook
    7.1 Japan Targeted DNA/RNA Sequencing Market Size (2012-2017)
    7.2 Japan Targeted DNA/RNA Sequencing Market Size and Market Share by Players (2016 and 2017)

8 China Targeted DNA/RNA Sequencing Development Status and Outlook
    8.1 China Targeted DNA/RNA Sequencing Market Size (2012-2017)
    8.2 China Targeted DNA/RNA Sequencing Market Size and Market Share by Players (2016 and 2017)

9 India Targeted DNA/RNA Sequencing Development Status and Outlook
    9.1 India Targeted DNA/RNA Sequencing Market Size (2012-2017)
    9.2 India Targeted DNA/RNA Sequencing Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Targeted DNA/RNA Sequencing Development Status and Outlook
    10.1 Southeast Asia Targeted DNA/RNA Sequencing Market Size (2012-2017)
    10.2 Southeast Asia Targeted DNA/RNA Sequencing Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Targeted DNA/RNA Sequencing Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2022)
        11.1.2 EU Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2022)
        11.1.4 China Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2022)
        11.1.5 India Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2022)
    11.2 Global Targeted DNA/RNA Sequencing Market Size (Value) by Type (2017-2022)
    11.3 Global Targeted DNA/RNA Sequencing Market Size by Application (2017-2022)

12 Targeted DNA/RNA Sequencing Market Dynamics
    12.1 Targeted DNA/RNA Sequencing Market Opportunities
    12.2 Targeted DNA/RNA Sequencing Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Targeted DNA/RNA Sequencing Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Targeted DNA/RNA Sequencing Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source